Lenz Therapeutics, Inc. <LENZ.O>: BofA Global Research Cuts to Neutral From Buy; Cuts Price Objective to $7 From $31
LENZ•Related News
FirstService Residential wins property management mandate for Sonata Condominium in Washington, DC
FSV•
Trimble Inc <TRMB.O>: Bernstein cuts target price to $73 from $85
TRMB•
Red Violet to present at Midwest IDEAS Investor Conference
RDVT•
Goldman Sachs pays up for downside protection
GS•
Oil falls on weaker demand outlook and higher US stocks
XLE•